Skip to content

EGHT CARE

Active
Public limited company·Activiteiten van verpleegkundigen en verloskundigen· 5 yrs active
Excelsiorlaan 44 ·1930 Zaventem, Belgium
KBO/BCE: BE 0753.612.893
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age5 yrs
Board1
Staff (FTE)28.7
Connections6

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of EGHT CARE is 0.1% (very low). The 2024 annual accounts show equity of €151k and a net result of €163k. Equity is growing by ~61.2% per year across the filed fiscal years. Its solvency ranks better than 26% of 382 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 02-07-2025, 29 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 02-07-2025 29 d early 2025-00225116
31-12-2023 31-07-2024 03-07-2024 28 d early 2024-00221945
31-12-2022 31-07-2023 17-07-2023 14 d early 2023-00245949
31-12-2021 31-07-2022 02-08-2022 2 d late 2022-20261253

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Lower-risk legal form

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Turnover€1.41M
EBIT margin-14.5%
Net result€163k
Working capital€241k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 02-07-2025 with the NBB · fiscal year 2024 · verkort
€-500k€0€500k€1.00M€1.50MRevenue 2021: €1.41M€1.41MOperating result 2021: €-205k€-205kNet result 2021: €-227k€-227kOperating result 2022: €-137k€-137kNet result 2022: €-171k€-171kOperating result 2024: €286k€286kNet result 2024: €163k€163k202120222024
RevenueOperating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~61.2%/year over 3 fiscal years, indicative, assuming unchanged policy.
€-400k€-200k€0€200k€400k2025: €244k (€232k - €256k)2026: €337k (€325k - €349k)2027: €429k (€417k - €442k)2021: €-127k2022: €-298k2024: €151k202120222024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 16.2% 50.3%
better than 26% of 382 sector peers
Net result €163k €72k
better than 71% of 372 sector peers
Equity €151k €127k
better than 54% of 382 sector peers
Gross operating margin €2.57M €179k
better than 95% of 372 sector peers
Staff costs €2.28M €134k
higher than 95% of 178 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P26
2021: P5 · n=1542022: P5 · n=2602024: P26 · n=3822021 2024
Improving position over 2021-2024 · n=154-382
Net result P71
2021: P5 · n=1532022: P5 · n=2562024: P71 · n=3722021 2024
Improving position over 2021-2024 · n=153-372
Equity P54
2021: P5 · n=1542022: P5 · n=2602024: P54 · n=3822021 2024
Improving position over 2021-2024 · n=154-382
Gross operating margin P95
2021: P81 · n=1482022: P93 · n=2532024: P95 · n=3722021 2024
Improving position over 2021-2024 · n=148-372
Describes the position versus peers, not a forecast.
Revenue
€1.41M
- 21-24
EBITDA
€291k
- 21-24
Net profit
€163k
- 21-24
Cash flow
€169k
- 21-24
Total assets
€933k
+97.3% 21-24
Equity
€151k
- 21-24
Working capital
€241k
- 21-24
Employees (FTE)
29
+71.9% 21-24
Staff costs
€2.28M
+116.8% 21-24
Income taxes
€99k
+3709.8% 21-24
Debt
€782k
+1.4% 21-24
Debt ≤ 1y
€677k
+1.6% 21-24
Debt > 1y
€100k
0.0% 21-24
Current ratio
1.36
+127.4% 21-24
Quick ratio
1.36
+127.4% 21-24
Solvency
16.2%
- 21-24
Debt / equity
5.16
- 21-24
ROE
107.8%
+87.5% 21-24
ROA
17.5%
- 21-24
Net margin
-16.1%
- 21-24
EBITDA margin
-14.4%
- 21-24
Interest coverage
6.51
- 21-24
Figures by fiscal year
Fiscal year2024
Depositverkort
Revenue-
EBITDA€291k
Net profit€163k
Cash flow€169k
Staff costs€2.28M
Income taxes€99k
Dividends-
Total assets€933k
Equity€151k
Debt€782k
of which ≤ 1y€677k
of which > 1y€100k
Working capital€241k
Employees (FTE)28.7
Ratios (computed)
2024
Current ratio1.36
Quick ratio1.36
Working capital ratio25.9%
Solvency16.2%
Debt / equity5.16
Long-term debt ratio0.66
Interest coverage6.51
Gross margin-
Net margin-
ROA17.5%
ROE107.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€933k
Fixed assets 21/28€8k
Formation expenses 20€7k
Intangible fixed assets 21€6k
Tangible fixed assets 22/27€2k
Financial fixed assets 28€80
Current assets 29/58€919k
Amounts receivable within one year 40/41€895k
Cash & bank 54/58€13k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€933k
Equity 10/15€151k
Contributions / capital 10/11€341k
Reserves 13€21k
Accumulated profits (losses) 14€-211k
Amounts payable 17/49€782k
Amounts payable after one year 17€100k
Amounts payable within one year 42/48€677k
Trade debts payable within one year 44€335k
Income statement
Gross operating margin 9900€2.57M
Operating result 9901€286k
Financial income 75€22k
Financial charges 65€45k
Result before taxes 9903€262k
Income taxes 67/77€99k
Net result for the period 9904€163k
Result to be appropriated 9905€163k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
76 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

1 director
Current directors & mandates
  • Bart Van den Eynde
    Managing director
    State Gazette act 20129032 (03-11-2020)
    Current
    02-09-2020 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Statutory auditor

1 auditor
Statutory auditor IRE/IBR number Tenure
Finvision BedrijfsrevisorenCurrent
Company auditor · represented by Dieter Engelen
A01962 09-02-2023 → present
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Activiteiten van verpleegkundigen en verloskundigen(86940)
Legal form Public limited company(014)
Incorporation02-09-2020
StatusActive
Postal code1930

Structure & network

Connections & network

6 connected companies
BelgieVacature.be, Shared address BBelgieVa…re.beNEXT ARCH, Shared address NANEXT ARCHSELECT GROUP, Shared address SGSELECT GROUPSelect HR - PS Services, Shared address SHSelect HR - PSServicesSELECT HUMAN RESOURCES, Shared address SHSELECT HUMANRESOURCESSELECT PROJECTS, Shared address SPSELECTPROJECTSEGHT CARE EGHT CARE0753.612.893
Shared address / shareholder
Network connections
BelgieVacature.be
Shared address
NEXT ARCH
Shared address
SELECT GROUP
Shared address
SELECT PROJECTS
Shared address
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
24 companies at this address See who is registered here

Establishment units

1 location
EGHT CARE
Excelsiorlaan 44, 1930 ZaventemOverige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
since 20202.307.112.831
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area6,488 m²
Buildings1
Building footprint1,924 m²
Volume (LiDAR)19,936 m³
Tallest building13.5 m · ±4 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23094D0036/00Z000 Flanders 6,488 m² 1 · 1,924 m² 13.5 m · 4 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

7 acts
Capital history · 2
26-05-2023
v3.2
18-04-2023
v3.2
Address history · 1
08-11-2022
v3.2
All acts · 7 updated 5 months ago
2026
24-02-2026 1 director appointed, 1 resigning Director changes
  • Bart Van den Eynde, Bestuurder
  • Bart Van den Eynde, Bestuurder
2025
14-11-2025 Dieter Engelen reappointed as statutory auditor Director changes
  • Dieter Engelen, Commissaris
Summary: v3.2
2023
26-05-2023 Capital increase of €241,342 to €341,342 Capital & shares
  • €100.000 → €341.342
Summary: v3.2
18-04-2023 Capital increase Capital & shares
09-02-2023 DIETER ENGELEN appointed as statutory auditor Director changes
  • DIETER ENGELEN, Commissaris
Summary: v3.2
2022
08-11-2022 Registered office moved from Kontich to Antwerpen Registered-office change
  • Satenrozen 10, 2550 Kontich → Transcontinentaalweg 13, 2030 Antwerpen
Summary: v3.2
2020
03-11-2020 Bart Van den Eynde appointed as managing director Director changes
  • Bart Van den Eynde, Gedelegeerd bestuurder
Summary: v3.2

Analysis

Snowflake analysis

financial profile on 5 axes
Health76Profitability100Solvency30Growth78Stability94
76 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 76
Profitability 100
Solvency 30
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Verpleegkundige activiteiten86906Activiteiten van verpleegkundigen en verloskundigen86940
Primary activity highlighted.
Names & trade names
Legal nameNL EGHT CARE
Registered office
Excelsiorlaan 44
1930 Zaventem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.